Evidence map›Paper›PMID 40494225›Full record

ArticleVaccine2025

Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) meeting, virtual gathering, 17-21 February 2025.

Philipp Lambach, Sheetal Silal, Alyssa N Sbarra, Mitsuki Koh, Rakesh Aggarwal, Habib Hasan Farooqui, Stefan Flasche, Alexandra B Hogan, Sun-Young Kim, Kathy Leung and 4 more

Abstract readConference Proceedings
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Philipp LambachImmunizations, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland.
Sheetal SilalModelling and Simulation Hub, Africa, University of Cape Town, Cape Town, South Africa; Centre for Global Health, Nuffield Department of Medicine, Oxford University, Oxford, United Kingdom.
Alyssa N SbarraJohns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States. Electronic address: asbarra1@jhu.edu.
Mitsuki KohImmunizations, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland.
Rakesh AggarwalSanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
Habib Hasan FarooquiCollege of Medicine, QU Health, Qatar University, Qatar.
Stefan FlascheCentre for Global Health, Charite, Berlin, Germany.
Alexandra B HoganSchool of Population Health, Faculty of Medicine and Health, UNSW, Sydney, Australia.
Sun-Young KimSeoul National University, Seoul, South Korea.
Kathy LeungSchool of Public Health, The University of Hong Kong, Hong Kong, SAR, China.
William J MossJohns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
Allison PortnoyDepartment of Global Health, Boston University School of Public Health, Boston, United States; Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, United States.
Meru SheelSchool of Public Health, Faculty of Medicine and Health, University of Sydney, Sydney, Australia; Sydney Infectious Diseases Institute, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
Xuan-Yi WangShanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China.

Funding

World Health Organization 001
6 · The paper itself

Abstract

The Immunization and Vaccines-related Implementation Research Advisory Committee (IVIR-AC) serves as the World Health Organization's (WHO) key advisory body for independently reviewing research that assesses the impact and value of vaccines, particularly using transmission and economic modeling analyses. During its first semi-annual meeting of 2025, held on 17-21 February and complemented by ad hoc sessions on 5 February, 11 April and 14 April, IVIR-AC provided feedback and recommendations across seven key sessions. This report summarizes the discussions and outcomes of the meeting. Topics covered included immunization research priorities in the WHO Eastern Mediterranean region, multi-model comparisons of typhoid conjugate vaccine schedules, a malaria intervention multi-model comparison, a full value assessment of invasive non-typhoidal Salmonella (iNTS) vaccination, an evaluation of improved influenza vaccines, vaccine impact modeling under the Immunization Agenda 2030 (IA2030) framework, and combination vaccines value assessment.

Indexed as

Advisory CommitteesImmunizationImmunization ProgramsVaccinesHumansImmunization ScheduleInfluenza VaccinesMalaria VaccinesTyphoid-Paratyphoid VaccinesVaccinationWorld Health OrganizationInfluenza VaccinesMalaria VaccinesTyphoid-Paratyphoid VaccinesVaccinesImmunizationIVIR-ACVaccination

Identifiers

PMID40494225
PMCPMC12447087

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.